These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

259 related articles for article (PubMed ID: 10843658)

  • 21. Soluble HLA-G1 inhibits angiogenesis through an apoptotic pathway and by direct binding to CD160 receptor expressed by endothelial cells.
    Fons P; Chabot S; Cartwright JE; Lenfant F; L'Faqihi F; Giustiniani J; Herault JP; Gueguen G; Bono F; Savi P; Aguerre-Girr M; Fournel S; Malecaze F; Bensussan A; Plouët J; Le Bouteiller P
    Blood; 2006 Oct; 108(8):2608-15. PubMed ID: 16809620
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Protein kinase C inhibits CD95 (Fas/APO-1)-mediated apoptosis by at least two different mechanisms in Jurkat T cells.
    Ruiz-Ruiz C; Robledo G; Font J; Izquierdo M; López-Rivas A
    J Immunol; 1999 Nov; 163(9):4737-46. PubMed ID: 10528172
    [TBL] [Abstract][Full Text] [Related]  

  • 23. CD4+ T cells inhibit growth of Epstein-Barr virus-transformed B cells through CD95-CD95 ligand-mediated apoptosis.
    Wilson AD; Redchenko I; Williams NA; Morgan AJ
    Int Immunol; 1998 Aug; 10(8):1149-57. PubMed ID: 9723701
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Role of the CD95/CD95 ligand system in glucocorticoid-induced monocyte apoptosis.
    Schmidt M; Lügering N; Lügering A; Pauels HG; Schulze-Osthoff K; Domschke W; Kucharzik T
    J Immunol; 2001 Jan; 166(2):1344-51. PubMed ID: 11145719
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Fas ligand costimulates the in vivo proliferation of CD8+ T cells.
    Suzuki I; Martin S; Boursalian TE; Beers C; Fink PJ
    J Immunol; 2000 Nov; 165(10):5537-43. PubMed ID: 11067907
    [TBL] [Abstract][Full Text] [Related]  

  • 26. CD4+ T cells engrafted with a recombinant immunoreceptor efficiently lyse target cells in a MHC antigen- and Fas-independent fashion.
    Hombach A; Heuser C; Marquardt T; Wieczarkowiecz A; Groneck V; Pohl C; Abken H
    J Immunol; 2001 Jul; 167(2):1090-6. PubMed ID: 11441120
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Cutting edge: SDS-stable Fas microaggregates: an early event of Fas activation occurring with agonistic anti-Fas antibody but not with Fas ligand.
    Legembre P; Beneteau M; Daburon S; Moreau JF; Taupin JL
    J Immunol; 2003 Dec; 171(11):5659-62. PubMed ID: 14634070
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Skin graft rejection elicited by beta 2-microglobulin as a minor transplantation antigen involves multiple effector pathways: role of Fas-Fas ligand interactions and Th2-dependent graft eosinophil infiltrates.
    Surquin M; Le Moine A; Flamand V; Nagy N; Rombaut K; Demoor FX; Stordeur P; Salmon I; Guéry JC; Goldman M; Abramowicz D
    J Immunol; 2002 Jul; 169(1):500-6. PubMed ID: 12077281
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Induction of apoptosis in human mitogen-activated peripheral blood T-lymphocytes by the ether phospholipid ET-18-OCH3: involvement of the Fas receptor/ligand system.
    Cabaner C; Gajate C; Macho A; Muñoz E; Modolell M; Mollinedo F
    Br J Pharmacol; 1999 Jun; 127(4):813-25. PubMed ID: 10433487
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Soluble HLA-G and HLA-G1 expressing antigen-presenting cells inhibit T-cell alloproliferation through ILT-2/ILT-4/FasL-mediated pathways.
    Naji A; Durrbach A; Carosella ED; Rouas-Freiss N
    Hum Immunol; 2007 Apr; 68(4):233-9. PubMed ID: 17400057
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Immunosensitization of melanoma tumor cells to non-MHC Fas-mediated killing by MART-1-specific CTL cultures.
    Frost PJ; Butterfield LH; Dissette VB; Economou JS; Bonavida B
    J Immunol; 2001 Mar; 166(5):3564-73. PubMed ID: 11207317
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Inhibition of term decidual NK cell cytotoxicity by soluble HLA-G1.
    Poehlmann TG; Schaumann A; Busch S; Fitzgerald JS; Aguerre-Girr M; Le Bouteiller P; Schleussner E; Markert UR
    Am J Reprod Immunol; 2006; 56(5-6):275-85. PubMed ID: 17076671
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Clonal deletion of major histocompatibility complex class I-restricted CD4+CD8+ thymocytes in vitro is independent of the CD95 (APO-1/Fas) ligand.
    Müller KP; Mariani SM; Matiba B; Kyewski B; Krammer PH
    Eur J Immunol; 1995 Oct; 25(10):2996-9. PubMed ID: 7589104
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Immune homeostasis requires several biologic factors including glucocorticoid hormones.
    Cancedda C; Filaci G; Puppo F; Ghio M; Contini P; Indiveri F
    Ann N Y Acad Sci; 2002 Jun; 966():49-63. PubMed ID: 12114258
    [TBL] [Abstract][Full Text] [Related]  

  • 35. TCR stimulation protects CD8+ T cells from CD95 mediated apoptosis.
    Karas M; Zaks TZ; Yakar S; Dudley ME; LeRoith D
    Hum Immunol; 2001 Jan; 62(1):32-8. PubMed ID: 11165713
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Fas/APO-1 (CD95)-mediated cytotoxicity is responsible for the apoptotic cell death of leukaemic cells induced by interleukin-2-activated T cells.
    Komada Y; Zhou YW; Zhang XL; Chen TX; Tanaka S; Azuma E; Sakurai M
    Br J Haematol; 1997 Jan; 96(1):147-57. PubMed ID: 9012700
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A subclass of soluble HLA-G1 modulates the release of cytokines from mononuclear cells present in the decidua additively to membrane-bound HLA-G1.
    Kanai T; Fujii T; Kozuma S; Miki A; Yamashita T; Hyodo H; Unno N; Yoshida S; Taketani Y
    J Reprod Immunol; 2003 Dec; 60(2):85-96. PubMed ID: 14638437
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A noncomitogenic CD2R monoclonal antibody induces apoptosis of activated T cells by a CD95/CD95-L-dependent pathway.
    Fournel S; Robinet E; Bonnefoy-Bérard N; Assossou O; Flacher M; Waldmann H; Bismuth G; Revillard JP
    J Immunol; 1998 May; 160(9):4313-21. PubMed ID: 9574534
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Fas-mediated apoptosis causes elimination of virus-specific cytotoxic T cells in the virus-infected liver.
    Liu ZX; Govindarajan S; Okamoto S; Dennert G
    J Immunol; 2001 Mar; 166(5):3035-41. PubMed ID: 11207253
    [TBL] [Abstract][Full Text] [Related]  

  • 40. T cell receptor ligation triggers novel nonapoptotic cell death pathways that are Fas-independent or Fas-dependent.
    Davidson WF; Haudenschild C; Kwon J; Williams MS
    J Immunol; 2002 Dec; 169(11):6218-30. PubMed ID: 12444127
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.